KIF2C and neoplasm: We used cBioPortal to validate the specific genetic modifications associated with key prognostic kinesins (i.e., KIF11, KIF15, KIF18B, KIF20A, KIF2C, KIF4A, KIFC1) across LUAD dataset (TCGA, Firehose legacy) comprising \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$584$$\end{document}584 tumor patient samples.